Cargando…
Increased levels of YKL-40 in patients with diabetes mellitus: a systematic review and meta-analysis
BACKGROUND: Diabetes mellitus (DM) could be classified as type 1 diabetes mellitus (T1DM), type 2 diabetes mellitus (T2DM), gestational diabetes mellitus (GDM) and others according to etiology and pathology. Diabetic nephropathy (DN) is one of the most serious complications of DM. YKL-40 is a marker...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7809835/ https://www.ncbi.nlm.nih.gov/pubmed/33446257 http://dx.doi.org/10.1186/s13098-021-00624-9 |
_version_ | 1783637196045025280 |
---|---|
author | Luo, Wanwan Zhang, Lingmin Sheng, Lingling Zhang, Zhencheng Yang, Zaixing |
author_facet | Luo, Wanwan Zhang, Lingmin Sheng, Lingling Zhang, Zhencheng Yang, Zaixing |
author_sort | Luo, Wanwan |
collection | PubMed |
description | BACKGROUND: Diabetes mellitus (DM) could be classified as type 1 diabetes mellitus (T1DM), type 2 diabetes mellitus (T2DM), gestational diabetes mellitus (GDM) and others according to etiology and pathology. Diabetic nephropathy (DN) is one of the most serious complications of DM. YKL-40 is a marker of inflammation and some studies have indicated that DM was related with inflammation. The objective of our study is to perform a systematic review and meta-analysis to confirm the relationship between YKL-40 and DM as well as DN. METHODS: Pubmed, Embase, CNKI and Chinese wanfang databases were searched for eligible studies by two independent authors. Studies were included in this meta-analysis if they fulfilled the following inclusion criteria: (1) a study involving the role of YKL-40 in DM (or DN) designed as a case–control study or cohort study; (2) the data of serum YKL-40 levels were available; (3) studies were published in English or Chinese. Finally, twenty-five studies were included in this meta-analysis. RESULTS: Compared with healthy controls, DM patients had significantly higher levels of YKL-40 (DM: SMD = 1.62, 95% CI 1.08 to 2.25, P = 0.000; GDM: SMD = 2.85, 95% CI 1.01 to 4.70, P = 0.002). Additionally, DM patients with different degree of albuminuria had significantly higher levels of YKL-40 compared with healthy controls (normoalbuminuria: SMD = 1.58, 95% CI 0.59 to 2.56, P = 0.002; microalbuminuria: SMD = 2.57, 95% CI 0.92 to 4.22, P = 0.002; macroalbuminuria: SMD = 2.69, 95% CI 1.40 to 3.98, P = 0.000) and serum YKL-40 levels increased with increasing severity of albuminuria among DM patients (microalbuminuria vs normoalbuminuria: SMD = 1.49, 95% CI 0.28 to 2.71, P = 0.016; macroalbuminuria vs microalbuminuria: SMD = 0.93, 95% CI 0.34 to 1.52, P = 0.002). CONCLUSIONS: Our current meta-analysis demonstrates that serum level of YKL-40 is increased in DM and positively associated with the severe degree of albuminuria. Therefore, we suggest that YKL-40 could be considered to be detected, along with other inflammatory markers, if DM, especially DN, is suspected. |
format | Online Article Text |
id | pubmed-7809835 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-78098352021-01-18 Increased levels of YKL-40 in patients with diabetes mellitus: a systematic review and meta-analysis Luo, Wanwan Zhang, Lingmin Sheng, Lingling Zhang, Zhencheng Yang, Zaixing Diabetol Metab Syndr Research BACKGROUND: Diabetes mellitus (DM) could be classified as type 1 diabetes mellitus (T1DM), type 2 diabetes mellitus (T2DM), gestational diabetes mellitus (GDM) and others according to etiology and pathology. Diabetic nephropathy (DN) is one of the most serious complications of DM. YKL-40 is a marker of inflammation and some studies have indicated that DM was related with inflammation. The objective of our study is to perform a systematic review and meta-analysis to confirm the relationship between YKL-40 and DM as well as DN. METHODS: Pubmed, Embase, CNKI and Chinese wanfang databases were searched for eligible studies by two independent authors. Studies were included in this meta-analysis if they fulfilled the following inclusion criteria: (1) a study involving the role of YKL-40 in DM (or DN) designed as a case–control study or cohort study; (2) the data of serum YKL-40 levels were available; (3) studies were published in English or Chinese. Finally, twenty-five studies were included in this meta-analysis. RESULTS: Compared with healthy controls, DM patients had significantly higher levels of YKL-40 (DM: SMD = 1.62, 95% CI 1.08 to 2.25, P = 0.000; GDM: SMD = 2.85, 95% CI 1.01 to 4.70, P = 0.002). Additionally, DM patients with different degree of albuminuria had significantly higher levels of YKL-40 compared with healthy controls (normoalbuminuria: SMD = 1.58, 95% CI 0.59 to 2.56, P = 0.002; microalbuminuria: SMD = 2.57, 95% CI 0.92 to 4.22, P = 0.002; macroalbuminuria: SMD = 2.69, 95% CI 1.40 to 3.98, P = 0.000) and serum YKL-40 levels increased with increasing severity of albuminuria among DM patients (microalbuminuria vs normoalbuminuria: SMD = 1.49, 95% CI 0.28 to 2.71, P = 0.016; macroalbuminuria vs microalbuminuria: SMD = 0.93, 95% CI 0.34 to 1.52, P = 0.002). CONCLUSIONS: Our current meta-analysis demonstrates that serum level of YKL-40 is increased in DM and positively associated with the severe degree of albuminuria. Therefore, we suggest that YKL-40 could be considered to be detected, along with other inflammatory markers, if DM, especially DN, is suspected. BioMed Central 2021-01-15 /pmc/articles/PMC7809835/ /pubmed/33446257 http://dx.doi.org/10.1186/s13098-021-00624-9 Text en © The Author(s) 2021 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Luo, Wanwan Zhang, Lingmin Sheng, Lingling Zhang, Zhencheng Yang, Zaixing Increased levels of YKL-40 in patients with diabetes mellitus: a systematic review and meta-analysis |
title | Increased levels of YKL-40 in patients with diabetes mellitus: a systematic review and meta-analysis |
title_full | Increased levels of YKL-40 in patients with diabetes mellitus: a systematic review and meta-analysis |
title_fullStr | Increased levels of YKL-40 in patients with diabetes mellitus: a systematic review and meta-analysis |
title_full_unstemmed | Increased levels of YKL-40 in patients with diabetes mellitus: a systematic review and meta-analysis |
title_short | Increased levels of YKL-40 in patients with diabetes mellitus: a systematic review and meta-analysis |
title_sort | increased levels of ykl-40 in patients with diabetes mellitus: a systematic review and meta-analysis |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7809835/ https://www.ncbi.nlm.nih.gov/pubmed/33446257 http://dx.doi.org/10.1186/s13098-021-00624-9 |
work_keys_str_mv | AT luowanwan increasedlevelsofykl40inpatientswithdiabetesmellitusasystematicreviewandmetaanalysis AT zhanglingmin increasedlevelsofykl40inpatientswithdiabetesmellitusasystematicreviewandmetaanalysis AT shenglingling increasedlevelsofykl40inpatientswithdiabetesmellitusasystematicreviewandmetaanalysis AT zhangzhencheng increasedlevelsofykl40inpatientswithdiabetesmellitusasystematicreviewandmetaanalysis AT yangzaixing increasedlevelsofykl40inpatientswithdiabetesmellitusasystematicreviewandmetaanalysis |